• LAST PRICE
    1.3300
  • TODAY'S CHANGE (%)
    Trending Up0.0400 (3.1008%)
  • Bid / Lots
    1.3200/ 58
  • Ask / Lots
    1.3300/ 126
  • Open / Previous Close
    1.3000 / 1.2900
  • Day Range
    Low 1.2750
    High 1.3400
  • 52 Week Range
    Low 1.1100
    High 5.9700
  • Volume
    685,980
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 1.29
TimeVolumeAMRN
09:32 ET450011.298
09:34 ET50001.29
09:36 ET82711.2899
09:38 ET93511.29
09:39 ET38001.29
09:41 ET76091.2922
09:43 ET665651.2999
09:45 ET17551.3
09:48 ET5461.29
09:50 ET21021.2914
09:52 ET18681.295
09:54 ET3270021.33
09:56 ET229071.33
09:57 ET1289151.33
09:59 ET195701.33
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAMRN
Amarin Corporation PLC
520.1M
-5.2x
---
United StatesNVTA
Invitae Corp
527.4M
-1.2x
---
United StatesICPT
Intercept Pharmaceuticals Inc
489.3M
-5.1x
---
United StatesQURE
Uniqure NV
1.2B
2.9x
---
United StatesAVIR
Atea Pharmaceuticals Inc
731.8M
17.4x
---
United StatesPIII
P3 Health Partners Inc
1.3B
-12.9x
---
As of 2022-08-08

Company Information

Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics for cardiovascular disease management. The Company operates through the development and commercialization of Vascepa segment. Its lead product, Vascepa (icosapent ethyl) capsule for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.

Contact Information

Headquarters
Gemini House, Bartholomews WalkDUBLIN, Ireland FK7 9JQ
Phone
---
Fax
---

Executives

Non-Executive Independent Chairman of the Board
Per Wold - Olsen
President, Chief Executive Officer, Director
Karim Mikhail
Chief Financial Officer, Senior Vice President
Thomas Reilly
Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary
Jason Marks
Executive Vice President, President - US
Aaron Berg

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$520.1M
Revenue (TTM)
$475.6M
Shares Outstanding
403.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.85
EPS
$-0.25
Book Value
$1.68
P/E Ratio
-5.2x
Price/Sales (TTM)
1.1
Price/Cash Flow (TTM)
---
Operating Margin
-18.52%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.